ESR1 and breast cancer: The finding that desensitization of ERα-positive breast cancer cells to the anti-estrogen fulvestrant was accompanied by a decline in TMEM26 RNA expression [10] prompted us to compare TMEM26 expression in ERα-dependent and ERα-independent breast cancer cell lines.